$76.01—
Real-time prices · US MarketsClean balance sheet with low leverage (0.5× debt-to-equity).
cautious analyst consensus — few Buy ratings.
Quality
7
Health
9.2
Growth
4.4
Valuation
6.5
Sentiment
2.5
Analyst Target
$76.67
▲ +0.9% from current
Price Chart
Latest News
- Inflation Could 'Wipe Out Social Security,' 'Rich Dad Poor Dad' Author Robert Kiyosaki Warns — Says 'Your Mommy And Daddy May Be On The Street'
- The Sandbox Announces Its Inaugural Cohort of Artist Residents in Joshua Tree
- Everads Announces Publication of First-in-Human Clinical Data for Its Suprachoroidal Injector in Ophthalmology Science and Three Presentations at ARVO 2026
Fundamentals
Trailing P/E
31.5×
price-to-earnings
Forward P/E
15.6×
next 12 months est.
Market Cap
$17.0B
market capitalization
Div Yield
—
dividend yield
Profit Margin
13.2%
net profit margin
Gross Margin
60.4%
revenue minus COGS
ROE
10.9%
return on equity
Beta
0.70
vs S&P 500
Price / Book
—
P/B ratio
52-Week Range
$52 — $76
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
Is HOLX a good stock to buy right now?
Hologic, Inc.'s Q·Score is 6.1/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. Clean balance sheet with low leverage (0.5× debt-to-equity). Key area to monitor: cautious analyst consensus — few Buy ratings. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for HOLX?
The consensus price target for HOLX is $76.67, based on ratings from 9 Wall Street analysts. This is 0.9% above the current price of $76.01. Price targets are forward-looking estimates and not guarantees of future performance.
Is HOLX overvalued or undervalued?
Hologic, Inc. (HOLX) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 15.6×.
What is Hologic, Inc.'s profit margin?
Hologic, Inc. has a net profit margin of 13.2%, which is solid for most industries. Its gross margin stands at 60.4%, indicating a high-margin business model.
Is Hologic, Inc.'s revenue growing?
Hologic, Inc. is reporting modest revenue growth of 2.5%. However, earnings declined 9.2%, which warrants monitoring.
How much debt does Hologic, Inc. have?
Hologic, Inc. has a debt-to-equity ratio of 0.48×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 4.04×, indicating comfortable short-term liquidity.